Please provide your email address to receive an email when new articles are posted on . The FDA approved a navigation-enabled ablation catheter for the treatment of ...
Pulsed field ablation (PFA) is as effective and safe as conventional thermal ablation for the treatment of paroxysmal atrial fibrillation (AF), according to late breaking research presented in a Hot ...
CLEVELAND — A new Cleveland Clinic study has shown promise for treating atrial fibrillation patients. The results point to ablation as a potentially more effective method treatment than the current ...
This release is available in Chinese. Use of catheter ablation, in which radiofrequency energy is emitted from a catheter to eliminate the source of an irregular heartbeat, resulted in significantly ...
Pulmonary-vein isolation is an effective treatment for paroxysmal atrial fibrillation. Pulsed field ablation (PFA) is a nonthermal ablation method with few adverse effects beyond the myocardium. Data ...
PFA was noninferior to cryoablation for first recurrence of atrial tachyarrhythmia in patients with paroxysmal atrial fibrillation. Tissue-selective energy delivery and short application times offer ...
MARLBOROUGH, Mass., June 16, 2020 /PRNewswire/ -- CardioFocus, Inc. today announced that the first U.S. patients have been treated commercially with the recently-approved HeartLight ® X3 Endoscopic ...
Please provide your email address to receive an email when new articles are posted on . Primary efficacy failure was defined as subsequent surgery or ablation treatment for AF; AF, atrial flutter or ...
Findings from the admIRE study – freedom from atrial arrhythmia recurrence at 12 months – support the submission of the VARIPULSE™ Platform among U.S. patients IRVINE, Calif., March 25, 2024 ...
Even though the use of rhythm control strategies for treating Paroxysmal Atrial Fibrillation (AF), a common abnormal heart rhythm, have increased overall in the United States, patients from racial and ...
MINNEAPOLIS – Medtronic, Inc. today announced the first patient was enrolled in the FIRE AND ICE clinical trial, which is a prospective, randomized, multinational head-to-head clinical trial comparing ...
DUBLIN, Jan. 29, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results